Phase I study of ontuxizumab, a humanized monoclonal antibody (mAb) recognizing endosialin in Japanese patients (pts) with hepatocellular carcinoma (HCC).

被引：0
作者：
Ikeda, Masafumi
Aramaki, Takeshi
Inaba, Yoshitaka
Nakai, Kenya
Doi, Toshihiko
Okusaka, Takuji
机构：
[1] Natl Canc Ctr Hosp East, Chiba, Japan
[2] Shizuoka Canc Ctr, Shizuoka, Japan
[3] Aichi Canc Ctr Hosp, Dept Intervent & Diagnost Radiol, Nagoya, Aichi 464, Japan
[4] Eisai & Co Ltd, Tokyo, Japan
[5] Natl Canc Ctr, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.2521
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2521
引用
收藏
页数：1
相关论文
共 50 条
[31]   A phase I study of 99mTc-h-R3 monoclonal antibody (DiaCIM ®), a humanized monoclonal antibody (mAB) for imaging EGFR-positive malignancies. [J].
Reilly, RM ;
Vallis, K ;
Chen, P ;
Oza, A ;
Hendler, A ;
Cameron, R ;
Hershkop, M ;
Keene, P .
JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) :311P-312P
[32]   A phase I trial of escalating doses of the anti-IGF-1R monoclonal antibody (mAb) cixutumumab (IMC-A12) and sorafenib for treatment of advanced hepatocellular carcinoma (HCC) [J].
O'Donnell, R. ;
El-Khoueiry, A. B. ;
Lenz, H. ;
Gandara, D. R. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[33]   A First-in-Human Phase I Study of MORAb-004, a Monoclonal Antibody to Endosialin in Patients with Advanced Solid Tumors [J].
Diaz, Luis A., Jr. ;
Coughlin, Christina M. ;
Weil, Susan C. ;
Fishel, Jean ;
Gounder, Mrinal M. ;
Lawrence, Susan ;
Azad, Nilofer ;
O'Shannessy, Daniel J. ;
Grasso, Luigi ;
Wustner, Jason ;
Ebel, Wolfgang ;
Carvajal, Richard D. .
CLINICAL CANCER RESEARCH, 2015, 21 (06) :1281-1288
[34]   Nivolumab (Nivo) in Patients (Pts) With Advanced Hepatocellular Carcinoma (HCC): the CheckMate 040 Study [J].
Melero, Ignacio ;
Sangro, Bruno ;
Yau, Thomas ;
Hsu, Chiun ;
Kudo, Masatoshi ;
Crocenzi, Todd S. ;
Kim, Tae-You ;
Choo, Su-pin ;
Trojan, Jorg ;
Meyer, Timothy ;
Welling, Theodore ;
Yeo, Winnie ;
Chopra, Akhil ;
Anderson, Jeffrey ;
Delacruz, Christine ;
Lang, Lixin ;
Neely, Jaclyn ;
Tang, Hao ;
El-Khoueiry, Anthony B. .
HEPATOLOGY, 2016, 64 (06) :1124A-1124A
[35]   Extended linifanib therapy in patients (pts) with advanced hepatocellular carcinoma (HCC) in a phase II trial [J].
Chen, P. J. ;
Yong, W. ;
Carr, B. I. ;
Sato, T. ;
Qin, Q. ;
Qian, J. ;
Ansell, P. J. ;
McKeegan, E. M. ;
McKee, M. D. ;
Ricker, J. L. ;
Carlson, D. M. ;
Toh, H. C. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[36]   A phase I study of EMD 525797, a novel humanized monoclonal antibody to human integrin alpha v, in Japanese patients with solid tumor. [J].
Doi, Toshihiko ;
Fuse, Nozomu ;
Bando, Hideaki ;
Kojima, Takashi ;
Watanabe, Morihiro ;
Yoshino, Takayuki ;
Ohtsu, Atsushi .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[37]   A phase I study of temsirolimus as novel therapeutic drug for patients with unresectable hepatocellular carcinoma (HCC). [J].
Chan, Stephen Lam ;
Mo, Frankie ;
Hui, Edwin P. ;
Koh, Jane ;
Chu, C. M. ;
Hui, Joyce ;
Li, Leung ;
Loong, Herbert H. ;
Ho, Wing Ming ;
Ma, Brigette ;
To, Ka Fai ;
Yu, Simon ;
Chan, Anthony T. C. ;
Yeo, Winnie .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[38]   Phase I dose-escalation study of nintedanib in Japanese patients with advanced hepatocellular carcinoma (HCC) and mild or moderate liver impairment [J].
Ikeda, M. ;
Otsuka, T. ;
Ueno, H. ;
Mitsunaga, S. ;
Sugimoto, R. ;
Muro, K. ;
Saito, I. ;
Sasaki, T. ;
Inoue, K. ;
Loembe, A. B. ;
Okusaka, T. .
EUROPEAN JOURNAL OF CANCER, 2015, 51 :S454-S454
[39]   Phase 2 study of XL184 (BMS-907351) in a cohort of patients (pts) with hepatocellular carcinoma (HCC) [J].
Van Cutsem, E. ;
Su, W. C. ;
Davis, J. ;
Haas, N. ;
Samuel, T. A. ;
Tsao, C. J. ;
Yang, T. S. ;
Brandy, H. ;
Mann, G. ;
Cohn, A. .
EJC SUPPLEMENTS, 2010, 8 (07) :129-130
[40]   Phase I/II trial of bortezomib in patients with unresectable hepatocellular carcinoma (HCC). [J].
Hegewisch-Becker, S ;
Sterneck, M ;
Schubert, U ;
Rogiers, X ;
Guerciolini, R ;
Pierce, JE ;
Hossfeld, DK .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :335S-335S
12345